Suchergebnisse - "Vandebosch, An"

PubPharm (6)

1

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features

enthalten in: Nature communications | 2024

von Magaret, C. | Li, L. | deCamp, A. | +47

UpdateOf: Res Sq. 2023 May 31;:. - PMID 37398105

2

Modifiers of COVID-19 vaccine efficacy : Results from four COVID-19 prevention network efficacy trials

enthalten in: Vaccine | 2023

von Turley, C. | Tables, L. | Fuller, T. | +33

3

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2) : results of a randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Infectious diseases | 2022

von Hardt, K. | Vandebosch, A. | Sadoff, J. | +115

CommentIn: Lancet Infect Dis. 2022 Dec;22(12):1654-1655. - PMID 36113536

4

Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial

enthalten in: Nature microbiology | 2022

von Fong, Y. | McDermott, A. | Benkeser, D. | +58

UpdateOf: medRxiv. 2022 Apr 12;:. - PMID 35441174

5

Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S

enthalten in: The New England journal of medicine | 2022

von Sadoff, J. | Gray, G. | Vandebosch, A. | +127

6

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

enthalten in: The New England journal of medicine | 2021

von Sadoff, J. | Gray, G. | Vandebosch, A. | +128

CommentIn: N Engl J Med. 2021 Jun 9;:. - PMID 34107178

1
[1]